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Background: The purpose of this case series is to report the one-year outcomes of small incision lenticule extraction
(SMILE) using the VisuMax® femtosecond laser.
Methods: Two hundred and six patients were recruited for this retrospective, single center study at TRSC International
LASIK Center in Bangkok, Thailand. Patients underwent SMILE, whereby an intrastromal lenticule was cut using a
femtosecond laser and then manually extracted without the need for flap creation. Outcome measures included
refraction, visual acuity and contrast sensitivity evaluation. Patients were treated and followed for one year.
Results: SMILE for the correction of low to high myopia was performed on 347 eyes of 206 patients. The mean
preoperative spherical equivalent was −4.96 ± 1.88 diopters (D). On the first day following surgery, for eyes with a plano
target refraction (99.14 % of all eyes), uncorrected distance visual acuity (UDVA) was 20/20 or better in 90 % of eyes. At
the one week postoperative exam, the mean spherical equivalent was 0.01 ± 0.36 D and UDVA was 20/20 or better in
84 % of eyes. After one year follow-up, no eyes showed loss of 2 or more lines of visual acuity and 31 % of eyes gained
one or more lines. The photopic contrast sensitivity of SMILE treated eyes at 12 and 18 cycles per degree (cpd) improved
from 1.59 and 0.94 preoperatively to 1.6 and 0.98, respectively, after one year.
Conclusions: In this series, SMILE using the VisuMax® femtosecond laser demonstrated that after one year it is an
effective, predictable and safe minimally invasive corneal refractive procedure.
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Laser refractive surgery has been performed for decades,
and there have been tremendous advancements in terms
of technique and technology, making it increasingly pre-
cise and highly predictable [1]. Laser in-situ keratomileusis
(LASIK) is currently the most common laser refractive
procedure for the treatment of myopia – its advantages
include early postoperative improvement in visual acuity
and minimal postoperative patient discomfort. Although
LASIK patients report 95 % satisfaction, a spectrum of
complicated side effects can negatively impact results [2].
Patient complaints may include visual distortions such as
glare, halos, dry eyes and decreased visual acuity in low
light [3]. Serious complications such as infection and in-
flammation associated with the creation of the corneal flap
have further significant consequences for LASIK patients.* Correspondence: echansue@lasikthai.com
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article, unless otherwise stated.The limitations of this procedure have already been proven
in long term (6-and 10-year follow-up) studies related to
the induction of aberrations and regression of correction
[4, 5]. The femtosecond laser has been used to cut LASIK
corneal flaps with high precision for over a decade [6, 7].
The ability to perform these highly accurate cuts to the
corneal tissue has sparked new enquiry into a method of
lamellar refractive surgery that may be less invasive.
Small incision lenticule extraction (SMILE) offers a
paradigm shift in laser vision correction by using a less
invasive technique that creates a lenticule inside the
intact cornea and subsequently removing it through an
incision, typically less than 4 mm in size [8]. ReLEx®
SMILE is performed using the VisuMax® femtosecond
laser (Carl Zeiss Meditec AG, Jena, Germany). Instead
of creating a corneal flap, a small side-cut incision is
created in the cornea for lenticule extraction. Theoret-
ically, by leaving the anterior cornea intact, surgeons
are able to maintain its biomechanical stability whileicle is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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a procedure that limits the damage to corneal nerve
fibers and preserves the biomechanical strength of the
cornea reduces the potential for patient discomfort and
flap-induced complications including incomplete and
irregular flap cuts, thin flaps, buttonholes and free caps,
as well as the associated risk of induced astigmatism,
and dry eye. Very promising initial safety and efficacy
results were first published by Sekundo et al. in 2008,
utilizing femtosecond lasers to create intrastromal
lenticule cut patterns to facilitate refractive lenticule
extraction through small incisions, eliminating the need
for flap creation [9]. Further studies have confirmed
that SMILE appears to be safe, predictable and effica-
cious in the correction of myopia [10–13].
The purpose of this study was to evaluate up to one year
results of 347 eyes treated for myopia and myopic astigma-
tism using ReLEx® SMILE procedure with the VisuMax®
femtosecond laser. This method includes the creation and
extraction of a refractive lenticule through a small incision
as an alternative to the creation and lifting of a hinged flap.
Methods
All participants were recruited at TRSC International
LASIK Center in Bangkok, Thailand, and were provided
written informed consent that explained the details of the
procedure and study protocol in accordance with the prin-
ciples of the Declaration of Helsinki. In order to be in-
cluded, patients had to be a minimum of 18 years of age,
have a myopic correction which had been stable for a year
or longer, best corrected visual acuity of 20/50 or better
and the ability to attend postoperative assessment time
points at 1 day, 1 week, 1 month, 3 months, 6 months and
1 year. Also, patients included had a minimum corneal
thickness of 475 μm, and minimum residual stromal bed
of 275 μm. Patients were excluded if they had any ocular
conditions other than myopia and/or astigmatism. All
surgeries were conducted by EC.
Assessments/outcome measurements
In order to assess the patient’s eligibility to participate in
the study procedure, all patients underwent a complete
eye examination, which included objective and mani-
fest visual acuity and refractions, pupil size evaluation,
intraocular pressure measurement, keratometric meas-
urement, slitlamp examination, complete fundoscopic
evaluation and contrast sensitivity assessment (Vistech
Contrast Sensitivity Chart). At each postoperative ap-
pointment, patients were assessed for best corrected
distance visual acuity (CDVA), uncorrected distance
visual acuity (UDVA) (Both were measured using the
ETDRS Visual Acuity Chart), objective and manifest
refractions, slitlamp examination, contrast sensitivity
assessment and applanation tonometry.Surgical technique
All surgeries in this study were performed by EC. After
application of topical anesthesia (Tetracaine Hydrochloride
0.5 %, Alcon Corporation, Switzerland), standard sterile
draping and insertion of the speculum, the patient’s eye was
centered and docked with the curved interface cone before
application of suction fixation. Unlike excimer laser tech-
niques, ReLEx® SMILE clearly defines the area where cuts
will be performed. The laser, for photo-dissection, is acti-
vated and initially cuts the posterior surface of the refractive
lenticule (spiral-in shot pattern) followed by creation of the
lenticule border. The anterior surface of the refractive lenti-
cule (spiral-out) is then formed which extends beyond the
posterior lenticule diameter by 0.5 mm to form the anterior
stromal layer (ASL), and is followed by a vertical curvilinear
cut to form the entrance wound. We used the following
femtosecond laser parameters: 100 μm ASL thickness,
7.5 mm anterior-plane cut diameter, 6.5 mm optical
zone of lenticule, 160 nJ of energy with lenticule side-
cut angles at 135°. A 2.1 mm entrance wound was
created centered between 9 and 12 o’clock in all cases.
The spot distance and tracking spacing are 4.5/4.5 μm
for the posterior lenticule plane, 2.5/2.5 μm for the
lenticule side-cut, 4.5/4.5 μm for the anterior lenticule
plane and 2.5/2.5 μm for the entrance wound side-cut.
After the suction was released, a Sinsky hook was first
used to separate the entrance wound cut made by the
femtosecond laser, and then to identify the edge of the
lenticule under the ASL. A Chansue ReLEx® Dissector
(CRD) was then used to separate the posterior surface
of the ASL from the anterior surface of the lenticule
and then to release the lenticule from its bed. The len-
ticule was then grasped and extracted with a pair of
non-toothed serrated microforceps through the small
incision.
Statistical analysis
All patient demographic and baseline information, as well
as outcome measurement data were entered into Microsoft
Excel (Microsoft Corporation, Redmond, Washington,
USA). Statistical analyses were performed using the data
analysis features of Microsoft Excel. Analysis of visual
acuity results were performed by calculating the geometric
mean with standard deviation into logMAR format from
Snellen examination results [14].
Results
A total of 347 eyes (206 patients, 188 right eyes and 159 left
eyes) were treated for myopia and myopic astigmatism
using the ReLEx® SMILE procedure. Baseline characteristics
of treated patients are listed in Table 1. Of particular note is
the eyes with up to −10.0 D of myopia and −3.75 D of astig-
matism included in this series. Three hundred nineteen
eyes (92 %) were evaluated at one year postoperatively.
Table 1 Patient characteristics at baseline and one year
Baseline (n = 347) One Year (n = 319)
92 % follow-up rate
Age at time of Surgery (years)
31 ±7 (18–56)
Gender 31 % Male/69 % Female
Spherical Equivalent (D)
−4.96 ± 1.88 (−1.0 to −10.5) 0.09 ± 0.31 (1.125 to −1.25)
Sphere (D)
−4.61 ± 1.85 (−0.75 to −10.0) 0.17 ± 0.3 (1.25 to −1.75)
Cylinder (D)
−0.71 ± 0.61 (0.0 to −3.75) −0.17 ± 0.34 (1.0 to −1.25)
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and 94 % had a UDVA of 20/25 or better at 1 day postoper-
atively. UDVA remained stable, with 95 % of eyes achieving
20/25 or better after one year. Figure 1 illustrates the per-
centage of all eyes (n = 347) in which the target refraction
was plano that reached the desired levels of UDVA. There
were no eyes, at any of the specified time points up to one
year, that lost two or more lines of CDVA.
Figure 2 illustrates the spherical equivalent (SE) at one
year postoperatively as a scatterplot of attempted versus
achieved refraction for all eyes. The mean SE at one year
was 0.09 ± 0.31 D. The mean astigmatism at one year (n =
319) was 0.17 ± 0.34 D.
At 1 year, 93 % of ReLEx® SMILE treated eyes were
within ± 0.5 D of the intended refractive target and 99 %
were within ± 1.0 D. Figure 3 illustrates the stability of the
refractive change over time by plotting the mean SE at each
of the follow-up time points, 0.10 D at 1 month, 0.07 D at
3 months, 0.08 D at 6 months and 0.09 D after 1 year.Fig. 1 Cumulative proportion of eyes with plano target refraction achievin
1 month, 3 months, 6 months and 1 yearThere was a moderate increase in photopic contrast
sensitivity (CS) after 1 year at 12 cpd (1.59 to 1.6) and
18 cpd (0.94 to 0.98), and a similar decrease at 3 cpd
(1.82 to 1.78) and 6 cpd (1.99 to 1.97) (Table 2).
No significant side effects or complications were
observed in any of the eyes in this study.
Discussion
Good visual outcomes, predictability of refractive correc-
tion, stability and safety are integral to the success of
refractive surgical procedures and are often the key out-
come measures. In this current case series, we have dem-
onstrated that refractive correction with ReLEx® SMILE
produced very promising results, adding to the existing
clinical evidence by previous SMILE studies by providing
follow-up outcomes of up to one year.
The published predictability of LASIK has ranged
widely from 78.2 % to 96.7 %, compared to 90.0 % to
95.6 % in previous predictability reports using SMILEg specific degrees of UDVA at each of the follow-up time points, 1 day,
Fig. 2 Scatterplot of the attempted spherical equivalent refraction against the achieved refractive change at 1 year
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they determined that 3 months after patients were
treated with SMILE, the achieved refraction was
0.25 ± 0.44 D less than the attempted correction, and
that 94 % of patients were within ±1.00 D [18]. Regres-
sion analysis determined that undercorrection could be pre-
dicted by increasing patient age (0.10 D per decade) and
steeper corneal curvature (0.04 D per D) [18]. Shah et al.
found in their 2011 study that 91 % of eyes at 6 monthsFig. 3 Mean spherical equivalent plotted as a function of time at each of twere within ±0.5 D of the intended correction, and 98 %
were within ±1.00 D when beginning with a mean pre-
operative SE of −4.87 ± 2.16 D [10]. Similarly, we found that
with our mean preoperative SE of −4.96 ± 1.88 D, 93 %
were within ±0.5 D of the intended correction and 99 %
were within ±1.00 D at 6 months. These values were main-
tained at the 1 year follow-up time point. Recently, Kamiya
et al. reported in their group of 52 eyes that 100 % of eyes
were within ±0.5 D of the intended correction after SMILE,he postoperative time points, illustrating the stability of the refraction
Table 2 Changes in photopic contrast sensitivity preoperatively
and after 3 months, 6 months and 1 year
3 cpd 6 cpd 12 cpd 18 cpd
Preop 329 Eyes 1.82 ± 0.15 1.99 ± 0.14 1.59 ± 0.19 0.94 ± 0.25
3 months 305 Eyes 1.79 ± 0.13 1.97 ± 0.14 1.59 ± 0.16 0.94 ± 0.22
6 months 295 Eyes 1.78 ± 0.12 1.97 ± 0.13 1.6 ± 0.16 0.98 ± 0.21
1 year 281 Eyes 1.78 ± 0.12 1.97 ± 0.12 1.6 ± 0.14 0.98 ± 0.19
Mean ± SD
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higher than previous studies due to slightly lower myopic
correction and the use of the newer generation femtosec-
ond laser [19].
Unlike the variable environmental factors, which are
difficult to mitigate and can cause inconsistencies in all
excimer laser ablations, ReLEx® SMILE is performed within
a closed system. The precision of the laser cut is independ-
ent from potential interference from particles, tissue hydra-
tion or fluctuating humidity levels of the ambient air
within the surgical suite, potentially eliminating the need
for the development of nomograms, tailored to specific
locations or surgeons. Additionally, ReLEx® SMILE leaves
the anterior lamellae intact. Being the strongest part of the
stroma, the anterior lamellae have biomechanical advan-
tages over both photorefractive keratectomy (PRK) and
LASIK [20]. Reinstein and colleagues developed a mathem-
atical model that calculated the stromal tensile strength
after PRK, LASIK and SMILE. They were able to predict
that the postoperative tensile strength after SMILE was
approximately 10 % higher than PRK and 25 % higher than
LASIK [20]. They further demonstrated that the postoper-
ative stromal tensile strength decreased with increasing
flap thickness by 0.22 %/μm in LASIK, but increased by
0.08 %/μm for greater cap thickness in SMILE. The model
predicted that SMILE lenticule thickness could be approxi-
mately 100 μm greater than the LASIK ablation depth and
still have equivalent corneal strength (equivalent to ap-
proximately 7.75 D), which means that SMILE can be ex-
pected to correct higher levels of myopia within the cornea
than is currently possible with LASIK or PRK [20]. In this
series, we were able to treat a higher level of myopia (SE up
to −10.5 D) and achieve optimum optical quality as well as
reduce aberrations, known to negatively affect night vision
[21]. In addition to devices which measure aberrations,
questionnaires may be used to assess the night vision qual-
ity following refractive surgery [22, 23].
Stability of the achieved refractive change is important to
monitor and highly influence clinical outcome and patient
satisfaction. Previous studies have shown good refractive
stability over the follow-up periods. Shah described refract-
ive stability by one week postoperatively and no further
significant change at 1 month [10]. Similarly, Sekundo and
colleagues reported that the patients in their study had astable refraction after one week and no further significant
change in SE was observed at 1 month (0.05 D), 3 months
(0.14 D) and 6 months (0.10 D) [10, 12]. In our study, the
changes in SE are in line with previous studies. We were
also able to follow our cohort for 1 year, observing a mean
SE of 0.10 D at 1 month (340 eyes), 0.07 D at 3 months
(321 eyes), 0.08 D at 6 months (323 eyes) and 0.09 D after
1 year (319 eyes). Additionally, in the patients that we have
examined after 2 years (214 eyes), the changes to SE were
only 0.06 D.
With regards to visual acuity, we found that 94 % of
our treated eyes with a target refraction of plano
(99.14 % of all eyes), achieved a UDVA of 20/25 or bet-
ter at 1 day postoperatively and 95 % had this same
result after one year. In previous studies, Vestergaard
et al. reported that 40 % and 73 % of their patients had
UDVA of 0.1 logMAR (20/25) or less postoperatively, at
1 day and 3 months, respectively; Shah et al. found that
79 % of their patients achieved a UDVA of 20/25 or
better at 6 months postoperatively [10, 11]. Looking at
visual acuity lines gained or lost after one year, 31 % of
our treated eyes gained one line, 1 % gained two lines,
and 8 % lost one line. Our results were quite similar to
the findings in 2011 by Sekundo et al., who after
6 months reported that 32.3 % of the patients gained
one line, 3.3 % gained two lines of best corrected spec-
tacle visual acuity, and 8.8 % lost one line [12].
Halos, glare and night vision complaints have been
reported by 17-20 % of LASIK patients which may be
caused by higher-order aberrations, particularly in low
light levels when the pupil is large [24, 25]. It is widely
accepted that with higher levels of LASIK correction,
there is a greater potential for increases in higher-
order aberrations. In addition, ignoring the effects of
ablation on higher order aberrations, LASIK flap cre-
ation itself increases higher order aberrations [26].
However, the single, small vertical cut used in ReLEx®
SMILE minimizes collapse or stromal damage, indu-
cing fewer aberrations, leading to better quality of
vision.
Conclusions
Based on our results in using ReLEx® SMILE for the
correction of myopia and myopic astigmatism, we
conclude that the procedure is safe, highly predictable
and very efficacious. However, in future studies, we
recommend a longer follow-up period after surgery.
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